Project Details
| Acronym | CO42865 |
|---|---|
| Status | Active |
| Effective start/end date | 30/04/22 → 30/04/27 |
CTU: A Phase III, Randomized, Open-Label Study of Pralsetinib Versus Standard of Care for Treatment of Ret-Mutated Medullary Thyroid Cancer
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
Project: Research